Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
19/10/2012
19/10/2012
2009
|
Resumo |
Introduction: Hyaluronidases (HAases) are enzymes related to cancer progression. Isoforms of HAases have been described as products of alternative splicing responsible for differences in enzyme activity. The heterogeneity of HAase expression has been identified in tumors and could be related to the differences in their biological behavior. Methods: Thirty-seven patients subjected to radical prostatectomy for prostate cancer were divided into 2 groups for the analyses: Low (<= 6-18) and high (>= 7-19) Gleason score and tumor behavior; recurrence 15 and nonrecurrence 22, mean follow-up 52.6 months. Conclusion: A profile of HAase related to low Gleason score and non-tumor recurrence was characterized by expression of HYAL3-v1, HYAL1-v3, and HYAL3-v2. More studies should be made in order to confirm with larger series. (C) 2009 Elsevier Inc. All rights reserved. |
Identificador |
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, v.27, n.4, p.377-381, 2009 1078-1439 http://producao.usp.br/handle/BDPI/23271 10.1016/j.urolonc.2008.04.013 |
Idioma(s) |
eng |
Publicador |
ELSEVIER SCIENCE INC |
Relação |
Urologic Oncology-seminars and Original Investigations |
Direitos |
restrictedAccess Copyright ELSEVIER SCIENCE INC |
Palavras-Chave | #Hyaluronidases #Hyaluronan #Alternative splicing #Prostate cancer #Prognosis #CELL LUNG-CANCER #MESSENGER-RNA #EXPRESSION #ACID #ANGIOGENESIS #MARKERS #GROWTH #HYAL1 #Oncology #Urology & Nephrology |
Tipo |
article original article publishedVersion |